Learn the basics of embedded systems hacking with Arduino, Raspberry Pi & RTOS. Discover GPIO, interrupts, hands-on projects & TinyML for smart edge computing.

The Raspberry Pi Pico is the new kid on the microcontroller block. How does it compare to the long-established Arduino Nano?

I had this idea of building my own bicycle lighting system totally personalized, the lights would have the exact lighting ...

With all the materials needed in hand, it is time to get on with the build. The first thing to do is print out the 3D part you’ll need for this build. We have included the models above, but you can ...

Nano Labs (NASDAQ:NA) has entered into an at-the-market offering agreement to sell its shares of Class A ordinary shares having an aggregate offering price of up to $45M. Net proceeds from the sale ...

OpenAI has begun rolling out GPT-5, the latest iteration of its flagship language model, to all ChatGPT users. The company’s CEO Sam Altman called GPT-5 “a significant step along the path to AGI” ...

Arduino has created a Renesas RA4M1 microcontroller board in its Nano form-factor. Called Nano R4, it follows the Uno R4, the first Arduino to use the RA4M1. “Whether you’re working on a connected ...

New York, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on ...

OpenAI on Monday launched a new family of models called GPT-4.1. Yes, “4.1” — as if the company’s nomenclature wasn’t confusing enough already. There’s GPT-4.1, GPT-4.1 mini, and GPT-4.1 nano, all of ...

Rallybio Corporation (NASDAQ:RLYB) on Tuesday discontinued the RLYB212 program to prevent fetal and neonatal alloimmune thrombocytopenia (FNAIT). FNAIT is a condition where maternal antibodies, formed ...

Programming via ISP can be complex when you're not used to it (I can tell you from personal experience). Apart from the technique I explain in the tutorial, there are a multitude of other ways to use ...

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a potentially long-acting anti-myostatin antibody from AstralBio, Inc. In ...